13th World Congress on Alternatives and Animal Use in the Life Sciences đź“Ť Rio de Janeiro, Brazil | đź—“ Aug 31-Sep 4 At this year’s conference SenzaGen and Unilever co-chair a scientific symposium, where Dr Andy Forreryd will present how GARD® can be applied to derive a Point-of-Departure (PoD) for quantitative skin sensitization assessment. Session […]
Eurotox 2025 Athens, Greece | Sep 14-17 Booth #A24 Advancing NAMs for Skin Sensitization Testing Come meet us at this year's Eurotox and take part in our scientific activities, featuring an industry-hosted session, poster presentations, and the latest insights on GARD®. Discover how the method provides high performance, broad applicability, and quantitative potency information for […]
RIFM 2025 Information Exchange (INFOX®) Paris France Advancing Fragrance Safety Through Innovation, Science, and Collaboration Date: September 29, 2025 Location: Le MĂ©ridien Etoile, 81 Bd Gouvion-Saint-Cyr, 75017 Paris, France Come meet SenzaGen' skin sensitization experts Dr Andy Forreryd and Dr Tim Lindberg at this year's Research Institute for Fragrance Materials (RIFM) INFOX© meeting in Paris! […]
Understanding Biological Evaluation of Medical Devices Join the next Medicon Valley MedTech Network meeting in Lund to gain insights into the general principles of biological safety evaluation, what to consider, why it matters, and how upcoming changes to ISO 10993-1 may affect the process. SenzaGen's in vitro skin sensitization expert, Dr Andy Forreryd, will be […]
Using GARD® to derive PoDs and safe dose levels for skin sensitizers Chemicals | Natural Extracts | Complex Mixtures Join our upcoming webinar to explore how GARD® enables the derivation of Points of Departure (PoDs) for Quantitative Risk Assessment (QRA) and helps establish safe dose levels for identified sensitizers. With broad applicability to complex mixtures […]
ICT 2025 / IUTOX 17th International Congress of Toxicology đź“Ť Beijing, China | đź—“ October 15–18, 2025 Meet us at this year's ICT/IUTOX conference in Beijing, where SenzaGen's scientific team will share new insights on quantitative skin sensitization potency assessment and present results from the pre-validation study of GARD®skin Medical Device. What to connect with […]
ASCCT 14th Annual Meeting đź“Ť Gaithersburg, USA | đź—“ October 21–23, 2025 Meet us at this year's ASCCT annual meeting in Gaithersburg, where SenzaGen's scientific team will share new insights on quantitative skin sensitization potency assessment and present results from the pre-validation study of GARD®skin Medical Device. What to connect with us while you are […]
3rd Annual Medical Device Biocompatibility Conference Berlin, Germany | Nov 6-7 Come meet us at this year’s Medical Device Biocompatibility Conference in Berlin, where SenzaGen's chief scientist Henrik Johansson will present recent progress in applying New Approach Methodologies (NAMs) for skin sensitization testing within the ISO 10993 framework, including current regulatory developments and data from […]
Bringing high performance and extended applicability to Defined Approaches for Skin Sensitization (DASS) Join us for a special re-run of our popular webcast to learn more about the inclusion of GARD®skin in OECD TG 497 — what it means and how it can support your regulatory testing strategy. Defined Approaches for Skin Sensitization (DASS) is […]
NAMs for skin sensitization ISO 10993-10 Join us for an insightful webinar on the evolving role of New Approach Methodologies (NAMs) in biological safety testing of Medical Devices, with a special focus on skin sensitization – the area currently undergoing the most significant regulatory changes. As ISO standards advance toward reducing animal testing, understanding these […]
